CPT Codeset
|
|
| # |
CodeValue |
Description |
| 1 |
90281 |
Immune globulin (IG), human, for intramuscular use |
| 2 |
90283 |
Immune globulin (IGIV), human, for intravenous use |
| 3 |
90287 |
Botulinum antitoxin, equine, any route |
| 4 |
90291 |
Cytomegalovirus immune globulin (CMV-IGIV), human, for intravenous use |
| 5 |
90296 |
Diphtheria antitoxin, equine, any route |
| 6 |
90371 |
Hepatitis B immune globulin (HBIG), human, for intramuscular use |
| 7 |
90375 |
Rabies immune globulin (RIG), human, for intramuscular and/or subcutaneous use |
| 8 |
90376 |
Rabies immune globulin, heat-treated (RIG-HT), human, for intramuscular and/or subcutaneous use |
| 9 |
90378 |
Respiratory syncytial virus immune globulin (RSV-IgIM), for intramuscular use, 50 mg, each |
| 10 |
90379 |
Respiratory syncytial virus immune globulin (RSV-IGIV), human, for intravenous use |
| 11 |
90389 |
Tetanus immune globulin (TIG), human, for intramuscular use |
| 12 |
90393 |
Vaccinia immune globulin, human, for intramuscular use |
| 13 |
90396 |
Varicella-zoster immune globulin, human, for intramuscular use |
| 14 |
90470 |
H1N1 immunization administration (intramuscular, intranasal), including counseling when performed |
| 15 |
90476 |
Adenovirus vaccine, type 4, live, for oral use |
| 16 |
90477 |
Adenovirus vaccine, type 7, live, for oral use |
| 17 |
90581 |
Anthrax vaccine, for subcutaneous use |
| 18 |
90585 |
Bacillus Calmette-Guerin vaccine (BCG) for tuberculosis, live, for percutaneous use |
| 19 |
90620 |
Meningococcal recombinant
protein and outer membrane
vesicle vaccine, serogroup B, 2
dose schedule, for intramuscular |
| 20 |
90621 |
Meningococcal recombinant
lipoprotein vaccine, serogroup B,
3 dose schedule, for intramuscular use |
| 21 |
90630 |
Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use |
| 22 |
90632 |
Hepatitis A vaccine, adult dosage, for intramuscular use |
| 23 |
90633 |
Hepatitis A vaccine, pediatric/adolescent dosage-2 dose schedule, for intramuscular use |
| 24 |
90634 |
Hepatitis A vaccine, pediatric/adolescent dosage-3 dose schedule, for intramuscular use |
| 25 |
90636 |
Hepatitis A and hepatitis B (HepA-HepB), adult dosage, for intramuscular use |
| 26 |
90644 |
Meningococcal conjugate vaccine, serogroups C & Y and Hemophilus influenza B vaccine
(MenCY-Hib) |
| 27 |
90645 |
Haemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use |
| 28 |
90646 |
Haemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular use |
| 29 |
90647 |
Haemophilus influenza b vaccine (Hib), PRP-OMP conjugate (3 dose schedule), for intramuscular use |
| 30 |
90648 |
Haemophilus influenza b vaccine (Hib), PRP-T conjugate (4 dose schedule), for intramuscular use |
| 31 |
90649 |
Human Papilloma virus (HPV) vaccine, types 6, 11, 16, 18 (quadrivalent) 3 dose schedule, for intramuscular use |
| 32 |
90650 |
Human Papilloma virus (HPV) vaccine, types 16, 18, bivalent, 3 dose schedule, for intramuscular use |
| 33 |
90651 |
Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (HPV) |
| 34 |
90654 |
Influenza virus vaccine, split virus, preservative free, for intradermal use |
| 35 |
90655 |
Influenza virus vaccine, split virus, preservative free, for children 6-35 months of age, for intramuscular use |
| 36 |
90656 |
Influenza virus vaccine, split virus, preservative free, for use in individuals 3 years of age and above, for intramuscular use |
| 37 |
90657 |
Influenza virus vaccine, split virus, for children 6-35 months of age, for intramuscular use |
| 38 |
90658 |
Influenza virus vaccine, split virus, for use in individuals 3 years of age and above, for intramuscular use |
| 39 |
90659 |
Influenza virus vaccine, whole virus, for intramuscular or jet injection use |
| 40 |
90660 |
Influenza virus vaccine, live, for intranasal use |
| 41 |
90661 |
Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use |
| 42 |
90662 |
Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use |
| 43 |
90663 |
Influenza virus vaccine, pandemic formulation, H1N1 |
| 44 |
90664 |
Influenza virus vaccine, pandemic formulation, live, for intranasal use |
| 45 |
90665 |
Lyme disease vaccine, adult dosage, for intramuscular use |
| 46 |
90666 |
Influenza virus vaccine, pandemic formulation, split-virus, preservative free, for intramuscular use |
| 47 |
90668 |
Influenza virus vaccine, pandemic formulation, split-virus, for intramuscular use |
| 48 |
90669 |
Pneumococcal conjugate vaccine, polyvalent, for children under five years, for intramuscular use |
| 49 |
90670 |
Pneumococcal conjugate vaccine, 13 valent, for intramuscular use |
| 50 |
90672 |
Influenza virus vaccine, quadrivalent (LAIV), live, intranasal use |
| 51 |
90673 |
Influenza virus vaccine, trivalent, derived from recombinant DNA (RIV3), hemagglutnin (HA) protein only, preservative and antibiotic free, for intramuscular use |
| 52 |
90675 |
Rabies vaccine, for intramuscular use |
| 53 |
90676 |
Rabies vaccine, for intradermal use |
| 54 |
90680 |
Rotavirus vaccine, pentavalent, 3 dose schedule, live, for oral use |
| 55 |
90681 |
Rotavirus vaccine, human, attenuated, 2 dose schedule, live, for oral use |
| 56 |
90685 |
Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to children 6-35 months of age, for intramuscular us |
| 57 |
90686 |
Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to individuals 3 years of age and older, for intramuscular use |
| 58 |
90687 |
Influenza virus vaccine, quadrivalent, split virus, when administered to children 6-35 months of age, for intramuscular use |
| 59 |
90688 |
Influenza virus vaccine, quadrivalent, split virus, when administered to individuals 3 years of age and older, for intramuscular use |
| 60 |
90690 |
Typhoid vaccine, live, oral |
| 61 |
90691 |
Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use |
| 62 |
90692 |
Typhoid vaccine, heat- and phenol-inactivated (H-P), for subcutaneous or intradermal use |
| 63 |
90693 |
Typhoid vaccine, acetone-killed, dried (AKD), for subcutaneous use (U.S. military) |
| 64 |
90694 |
Influenza vaccine, quadrivalent, adjuvanted |
| 65 |
90696 |
Diphtheria, tetanus toxoids, acellular pertussis vaccine and poliovirus vaccine, inactivated (DTaP-IPV), when administered to children 4 years through 6 years of age, for intramuscular use |
| 66 |
90697 |
DTaP,IPV,Hib,HepB |
| 67 |
90698 |
Diphtheria, tetanus toxoids, and acellular pertussis vaccine, haemophilus influenza Type B, and poliovirus vaccine, inactivated (DTaP - Hib - IPV), for intramuscular use |
| 68 |
90700 |
Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), for use in individuals younger than seven years, for intramuscular use |
| 69 |
90700 |
Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), for use in individuals younger than seven years, for intramuscular use |
| 70 |
90701 |
Diphtheria, tetanus toxoids, and whole cell pertussis vaccine (DTP), for intramuscular use |
| 71 |
90702 |
Diphtheria and tetanus toxoids (DT) adsorbed for use in individuals younger than seven years, for intramuscular use |
| 72 |
90703 |
Tetanus toxoid adsorbed, for intramuscular use |
| 73 |
90704 |
Mumps virus vaccine, live, for subcutaneous use |
| 74 |
90705 |
Measles virus vaccine, live, for subcutaneous use |
| 75 |
90706 |
Rubella virus vaccine, live, for subcutaneous use |
| 76 |
90707 |
Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use |
| 77 |
90708 |
Measles and rubella virus vaccine, live, for subcutaneous use |
| 78 |
90710 |
Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use |
| 79 |
90712 |
Poliovirus vaccine, (any type(s)) (OPV), live, for oral use |
| 80 |
90713 |
Poliovirus vaccine, inactivated, (IPV), for subcutaneous or intramuscular use |
| 81 |
90714 |
Tetanus and diphtheria toxoids (Td) adsorbed, preservative free, for use in individuals seven years or older, for intramuscular use |
| 82 |
90714 |
TD preservative free. |
| 83 |
90714 |
Tetanus and diphtheria toxoids (Td) adsorbed for use in individuals seven years or older, for intramuscular use |
| 84 |
90715 |
Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), for use in individuals 7 years or older, for intramuscular use |
| 85 |
90716 |
Varicella virus vaccine, live, for subcutaneous use |
| 86 |
90717 |
Yellow fever vaccine, live, for subcutaneous use |
| 87 |
90720 |
Diphtheria, tetanus toxoids, and whole cell pertussis vaccine and Hemophilus influenza B vaccine (DTP-Hib), for intramuscular use |
| 88 |
90721 |
Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DTaP-Hib), for intramuscular use |
| 89 |
90723 |
Diphtheria, tetanus toxoids, acellular pertussis vaccine, Hepatitis B, and poliovirus vaccine, inactivated (DTaP-HepB-IPV), for intramuscular use |
| 90 |
90724 |
Influenza virus vaccine |
| 91 |
90725 |
Cholera vaccine for injectable use |
| 92 |
90726 |
Rabies vaccine |
| 93 |
90727 |
Plague vaccine, for intramuscular use |
| 94 |
90728 |
BCG vaccine |
| 95 |
90730 |
Hepatitis A vaccine |
| 96 |
90731 |
Hepatitis B vaccine |
| 97 |
90732 |
Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient dosage, for use in individuals 2 years or older, for subcutaneous or intramuscular use |
| 98 |
90733 |
Meningococcal polysaccharide vaccine (any group(s)), for subcutaneous use |
| 99 |
90734 |
Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 (tetravalent), for intramuscular use |
| 100 |
90734 |
Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 (tetravalent), for intramuscular use |
| 101 |
90735 |
Japanese encephalitis virus vaccine, for subcutaneous use |
| 102 |
90736 |
Zoster (shingles) vaccine, live, for subcutaneous injection |
| 103 |
90737 |
Hemophilus influenza B |
| 104 |
90738 |
Japanese encephalitis virus vaccine, inactivated, for intramuscular use |
| 105 |
90740 |
Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (3 dose schedule), for intramuscular use |
| 106 |
90741 |
Immunization, passive; immune serum globulin, human (ISG) |
| 107 |
90743 |
Hepatitis B vaccine, adolescent (2 dose schedule), for intramuscular use |
| 108 |
90744 |
Hepatitis B vaccine, pediatric/adolescent dosage (3 dose schedule), for intramuscular use |
| 109 |
90745 |
Hepatitis B vaccine, adolescent/high risk infant dosage, for intramuscular use |
| 110 |
90746 |
Hepatitis B vaccine, adult dosage, for intramuscular use |
| 111 |
90747 |
Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (4 dose schedule), for intramuscular use |
| 112 |
90748 |
Hepatitis B and Hemophilus influenza b vaccine (HepB-Hib), for intramuscular use |
| 113 |
90750 |
Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use |
| 114 |
90756 |
Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use |
| 115 |
91300 |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose COVID-19 Vaccine - Potential EUA authorization |
| 116 |
91301 |
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose COVID-19 Vaccine - Potential EUA authorization |
|